{"public_id":"cl_dc3a0869289cb30f201cff4d26d4a204","status":"active","superseded_by_public_id":null,"corpus_id":1764643,"text":"Extramedullary disease is associated with shorter progression-free survival and overall survival in multiple myeloma patients, even in the era of novel agents.","confidence":0.95,"paper":{"corpus_id":1764643,"title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","url":"https://sah.borca.ai/papers/1764643"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1c0673ee51747ff65545ae7fe5c45706","name":"overall survival","description":"The length of time from diagnosis or start of treatment that a patient is still alive.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_1c0673ee51747ff65545ae7fe5c45706"},{"public_id":"co_4a4740f0a3f1a2377013c2ce91c3f5c5","name":"extramedullary disease","description":"An uncommon manifestation in multiple myeloma where plasma cells form tumors outside the bone marrow.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_4a4740f0a3f1a2377013c2ce91c3f5c5"},{"public_id":"co_9f44cbe0c8276044264cab1115206cd8","name":"progression-free survival","description":"The length of time during and after treatment that a patient lives without the disease worsening.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_9f44cbe0c8276044264cab1115206cd8"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_dc3a0869289cb30f201cff4d26d4a204"}